Dataset Information

Huntington disease mice exhibit a TCF7L2-responsive suppression of both homeostatic and compensatory remyelination

ABSTRACT: PDGFRA-EGFP+ striaal cells were isolated for bulk RNA-sequencing from R6/2 (6wk and 12wk) and zQ175 (12wk and 1yr) HD mice and littermate controls.

ORGANISM(S): Mus musculus

PROVIDER: GSE181370 | GEO | 2022/08/01

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other
	GSE181370_RSEM_counts.txt.gz	Txt

Items per page:

1 - 2 of 2

Similar Datasets

Project description:Cyclic GMP–AMP synthase (cGAS) and its downstream effector, stimulator of interferon genes (STING), form a central cytosolic DNA–sensing pathway that drives innate immune activation and pro-inflammatory cytokine production. We previously reported that cGAS is upregulated in Huntington disease (HD) cellular models, where it modulates autophagy and inflammatory signaling. However, its in vivo contribution to HD pathogenesis has remained unresolved. Here, we genetically ablated cGAS in zQ175 knock-in HD mice, a model that closely recapitulates hallmark features of human HD, and conducted longitudinal behavioral analyses from 2 to 14 months of age. cGAS deletion significantly ameliorated HD-associated motor impairments, as evidenced by improved rotarod performance, enhanced coordination on beam walk, and better outcomes across a comprehensive behavioral battery. It also mitigated the progressive body-weight loss characteristic of zQ175 mice. Analysis of brain sections further revealed that cGAS deletion reduced the enlargement of lateral ventricles and attenuated both astrogliosis and microgliosis in the striatum. While cGAS loss produced minimal effects in wild-type littermates, transcriptomic profiling of HD brains showed downregulation of genes associated with development and cell–cell communication (Mid1-ps1, Slc45a3, Ilvbl, Col5a3) and upregulation of transcripts linked to ion transport and synaptic activity (Pgam2, Nos1, Cort, RasGef1a). Targeted lipidomics uncovered elevated levels of bioactive immunoregulatory lipids—particularly 12-HETE (ω-6) and 12-HEPE (ω-3)—in HD mice lacking cGAS. Finally, to assess therapeutic potential of cGAS-STING pathway, we pharmacologically inhibited STING using H-151 in zQ175 mice, which led to improved age-dependent motor performance. Collectively, these findings identify cGAS as a critical contributor to HD pathogenesis and support cGAS–STING pathway inhibition as a promising therapeutic avenue for Huntington disease.

Dataset Information

Huntington disease mice exhibit a TCF7L2-responsive suppression of both homeostatic and compensatory remyelination

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets